All News
Filter News
Found 806,266 articles
-
Surgalign Holdings, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
11/30/2020
Surgalign Holdings, Inc. (Nasdaq: SRGA), a leading global pure-play spine company focused on advancing spine surgery and improving patient outcomes, today announced that the management team will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Thursday, December 3, 2020.
-
Zebra Medical Vision presents AI solutions in collaboration with global leaders Philips, Canon Medical Systems US, and Change Healthcare at RSNA
11/30/2020
Zebra Medical Vision, the deep-learning medical imaging analytics company, will be joining the 106th Radiological Society of North America (RSNA) this year, presenting its AI solutions with its global partners for the 6th year in a row.
-
MedX Health Corp. Announces Third Quarter 2020 Financial Results and Grant of Stock Options
11/30/2020
MedX Health Corp. (“MedX” or “Company”) (TSX-V: MDX) announced its results for the three and nine-months ended September 30, 2020, which are also available on SEDAR (www.sedar.com).
-
Iovance Biotherapeutics to Present at Upcoming Conferences in December
11/30/2020
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences in November: Piper Sandler 32nd Annual Virtual Healthcare Conference | December 1-3, 2020 Date/Time: presentation available at http://ir.iovance.com Cellular Immunotherapies for Solid Tumors Summit | December 1-
-
Emory University to Host a Live Webcast With His Holiness the Dalai Lama
11/30/2020
The Center for Contemplative Science and Compassion-Based Ethics at Emory University will host a live webinar with His Holiness the Dalai Lama on Tuesday, December 8, 2020. A discussion titled “The Necessity of Compassion for the Survival of Humanity” will feature the Dalai Lama in conversation with Melani A. Walt
-
GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference
11/30/2020
GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020 at 1:50 pm EST. A live audio webcast of the presentation will be available through GW’s corporate website at www.gwpharm.com in the Invest
-
Apnimed to Present at World Sleep Virtual Conference
11/30/2020
Apnimed, a clinical-stage pharmaceutical company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders, today announced that Dr. Luigi Taranto Montemurro, the company’s Medical Director will present at the World Sleep Conference, held virtually December 3-5, 2020. Dr.
-
iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020
11/30/2020
iCAD , Inc . (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Company is showcasing its leading Breast Health Solutions , including the expanded ProFound AI ® platform powered by Panorama, at the 106 th Scientific Assembly and virtual Annual Meeting of the Radiological Society of North America (RSNA), November 29 – December 5. The Company’s full sui
-
Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition
11/30/2020
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that new data on CPI-818, the Company’s ITK inhibitor, will be presented at the 62 nd American Society of Hematology (ASH) Annual Meeting & Exposition, which is taking place as an all-virtual event from December 5-8, 2020. This includes a poster presentation covering updated data from the Phase 1/1b clinical trial for T cell lymphom
-
Equillium to Host Virtual Investor and Analyst Day on December 4, 2020
11/30/2020
Equillium, Inc. (Nasdaq: EQ), today announced that it will host a virtual Investor and Analyst Day on December 4, 2020, from 9:30 a.m. to 12:00 p.m. ET.
-
Cidara Therapeutics to Present New Clinical Data for Rezafungin at ESICM LIVES 2020
11/30/2020
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present three posters at European Society of Intensive Care Medicine (ESICM) LIVES 2020, which takes place virtually Dec. 6-9, 2020. Cidara will highlight analyses from the completed Phase 2 STRIVE trial of rezafungin for
-
Scout Bio to Present at the Guggenheim Healthcare Talks Animal Health Veterinary Summit
11/30/2020
Scout Bio, a biotechnology company revolutionizing pet medicine by delivering a pipeline of one-time gene therapies for major chronic pet health conditions, today announced that Mark Heffernan, Scout Bio’s Chief Executive Officer, will present on the “Blockbusters of 2024” panel at the upcoming Guggenheim Healthcare Talks Animal Health Veterinary Summit at 1:20 p.m. ET on Monday, December 7, 2020. About Scout Bio Scout Bio is a biotechnology
-
CVS Health to Present at the Evercore ISI 3rd Annual HealthCONx 2020
11/30/2020
CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo , President and Chief Executive Officer; and Eva Boratto , Executive Vice President and Chief Financial Officer; and Karen Lynch , Executive Vice President and President of Aetna will be participating in a fireside chat with investors at the Evercore ISI 3rd
-
Moberg Pharma obtains positive decision from the Swedish Tax Agency regarding the Lex Asea distribution of the shares in OncoZenge
11/30/2020
Moberg Pharma AB (publ) ("Moberg Pharma" or the "Company") has obtained a positive decision confirming that the Swedish Tax Agency shares the Company's assessment that the Company's proposed distribution of the shares in OncoZenge qualifies as a Lex Asea distribution in accordance with chapter 42, section 16 of the Income Tax Act, whi
-
Masimo to Present in Piper Sandler Virtual Healthcare Conference
11/30/2020
Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler Virtual Healthcare Conference on Wednesday, December 2, 2020 at 3:30 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a globa
-
Spero Therapeutics to Present at the Evercore ISI HealthCONx Conference on December 3, 2020
11/30/2020
Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that Ankit Mahadevia, M.D., President and Chief Executive Officer of Spero Therapeutics, will participate in a fireside chat at the 3 rd Annual Evercore ISI HealthCONx Con
-
Samsung Introduces Its Latest Radiology Innovations at RSNA 2020
11/30/2020
Samsung to highlight its medical imaging portfolio with its latest radiology innovations in ultrasound, digital radiography and mobile computed tomography
-
Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts
11/30/2020
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will host a conference call and webcast featuring two experts in the science and treatment of chronic graft versus host disease (cG
-
TG Therapeutics to Participate in the 3rd Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Tuesday, December 1, 2020 at 10:05 AM ET
11/30/2020
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat during the 3rd Annual Evercore ISI HealthCONx Conference. The fireside chat is scheduled to take place on Tuesday, December 1, 2020 at 10:05 AM ET. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of th
-
Imara to Present Clinical Data on IMR-687 as Monotherapy and in Combination with Hydroxyurea in Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
11/30/2020
BOSTON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that clinical data from the ongoing IMR-687 Phase 2a open label extension (OLE) clinical trial in adult patients with sickle cell disease (SCD) will be presented at the 62 nd American Society of Hematology (ASH) Annual M